Results 13,081-13,100 of 21,588 for speaker:Denis Naughten

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Denis Naughten: I accept that it is not specific to this legislation, but the difficulty is that the enactment of the legislation will compound an existing problem. I know from first-hand experience that a person will ring up a health care professional and indicate that he is on a particular tablet and the professional will explain that it is for his heart. However, if the medications are being changed...

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Denis Naughten: That relates to the approved list and not to the fact that a pharmacist could administer medicines A, B and C to a patient in three consecutive months. The legislation is weak at the consumer end and it needs to be strengthened.

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Denis Naughten: The human dimension cannot be forgotten. In some cases, there may be a number of brands of a product that can be substituted. One can have Mrs. Murphy, for example, receiving brand A for her heart condition for the past six years but receiving brand B one day and brand C on another. This may be only one of her medications, as she could be on 15 tablets for 15 conditions. This switch could...

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Denis Naughten: I made the point about pharmacists switching products.

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Denis Naughten: I was not questioning the professional competency of pharmacists in the matter. The point I was making was that in the instances to which I referred, pharmacists did not inform customers that they were replacing branded products with generic substitutes. There is provision for this to happen in the legislation, but there is no such provision in the existing legislation.

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Denis Naughten: This is an important issue and we have received many representations on this. We have also had hearings and I want clarification. I thank the Minister of State for his response. I again refer to the shoe analogy. If he goes into a shoe shop tomorrow morning to buy a pair of shoes and picks a pair out and the retailer says he has another pair in the same size that look the same but are...

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Denis Naughten: I echo the comments made by the two previous speakers and do not want to go over them again, but those speakers articulated the concerns, as has the Chairman, that have been given in evidence by representatives of people with epilepsy and in individual representations we have received. For a person with epilepsy, anti-epileptic drugs are like a pair of shoes. One cannot give someone a...

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Denis Naughten: It is on that issue but we will deal with it when we come to the section. I have a brief question on section 1 regarding aids and appliances. General aids and appliances would not come under the legislation but where a particular piece of equipment could have an impact on the treatment of a specific condition as a replacement for a pharmacological treatment, is provision made for that in...

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Denis Naughten: The reason I asked the question is that for people on medication for pain relief, there are ways of treating pain relief other than through medicine. Sadly, the medicine people are taking while waiting for a hip replacement can have a damaging impact on the body. If at a future date a device was developed that would provide pain relief and would be an effective substitute for medicine,...

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Denis Naughten: We are dealing with food as well as medicine.

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Denis Naughten: Yes, so it is not purely medicine.

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Denis Naughten: Perhaps the Minister of State would examine it for Report Stage. What we are talking about is the substitution of a device for treatment in the case of pain relief. The Minister of State is talking about substituting one medicine for another medicine, or one tablet for another tablet, for pain relief on a more cost effective basis where it has the same treatment for the individual. If a...

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Denis Naughten: If the Minister of State can clarify that legislation is not required for such a system to be put in place in the future I am happy enough with that.

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Denis Naughten: Yes.

Joint Oireachtas Committee on Health and Children: Challenges Pertaining to Epilepsy in Ireland: Discussion (14 Mar 2013)

Denis Naughten: I thank the delegates for their evidence. Some months ago Senator Tony Mulcahy bent my ear on this issue and he has been pressing a number of us on it in recent months. What we are discussing is not alien to most of us. Our former colleague, the late Senator and Deputy Joe Doyle, had epilepsy. He was a great advocate for people with epilepsy and a great role model. What is the legal...

Written Answers — Department of Defence: Defence Forces Personnel (14 Mar 2013)

Denis Naughten: To ask the Minister for Defence the number of medical staff within the Defence Forces; the number who have a psychiatric qualification; the number in each category serving in a medical role here and overseas; and if he will make a statement on the matter. [13150/13]

Written Answers — Department of Defence: Air Ambulance Service (14 Mar 2013)

Denis Naughten: To ask the Minister for Defence the plans, if any, he has to expand the role of the Air Corps air ambulance service; and if he will make a statement on the matter. [13149/13]

Written Answers — Department of Social Protection: Child Benefit Eligibility (14 Mar 2013)

Denis Naughten: To ask the Minister for Social Protection her Department's policy on the payment of child benefit to children and their parents who do not reside in Ireland during the summer months out of school term; and if she will make a statement on the matter. [13488/13]

Finance Bill 2013: Report Stage (Resumed) and Final Stage (13 Mar 2013)

Denis Naughten: It is not a double payment but one pays for the full year even if one is with the insurer for four months. The lead insurer pays it. Perhaps someone in the Department can revert to me.

Finance Bill 2013: Report Stage (Resumed) and Final Stage (13 Mar 2013)

Denis Naughten: Yes.